| Portal hypertension related UGIB | Non related portal hypertension UGIB | p |
Age (years) | 43.02 ± 14.05 | 46.06 ± 17.64 | 0.210 |
Sex (male) | 76.12% | 69.88% | 0.339 |
Hepatic insufficiency | 90.47% | 9.53% | <0.001 |
Chronic liver disease | 92.85% | 7.15% | <0.001 |
Ethylism | 32.91% | 67.09% | 0.330 |
Non-steroidal anti-inflammatory | 14.86% | 85.14% | 0.001 |
Abdominal pain | 22.40% | 77.60% | 0.021 |
Automedication | 21.29% | 78.71% | 0.022 |
Arterial hypertension | 08.57% | 91.43% | 0.003 |
Syncope | 25% | 75% | 0.677 |
Altered consciousness | 28.38% | 71.62% | 0.123 |
Hepatic insufficiency signs | 88.88% | 11.12% | <0.001 |
Portal hypertension signs | 88% | 12% | <0.001 |
Hemoglobin rate (g/dl) | 07.24 ± 2.31 | 08.99 ± 3.49 | <0.001 |
White blood cells (/ml) | 8648 ± 6847 | 8237 ± 5102 | 0.627 |
Platelets (/ml) | 141,612 ± 16,110 | 198,945 ± 8847 | <0.001 |
Urea (g/l) | 0.50 ± 0.52 | 0.53 ± 0.47 | 0.708 |
Creatininemia (mg/l) | 12.74 ± 9.67 | 19.31 ± 29.63 | 0.100 |
Prothrombin rate | 54.90 ± 15.35 | 71.11 ± 19 | <0.001 |
Albumin (g/l) | 31.15 ± 7.54 | 28.83 ± 11.97 | 0.081 |
ASAT (UI/l) | 229 ± 911 | 111 ± 333 | 0.218 |
ALAT (UI/l) | 86.57 ± 146.02 | 82.93 ± 242.24 | 0.919 |
Rebleeding | 54.83% | 45.16% | 0.001 |
Death | 71.42% | 28.58% | <0.001 |
FRS | 4.85 ± 1.34 | 3.53 ± 1.34 | <0.001 |
CRS | 1.95 ± 1.59 | 1.09 ± 0.93 | <0.001 |
GBS | 10.58 ± 3.26 | 8.86 ± 3.40 | <0.001 |
mGBS | 9.08 ± 2.73 | 8.04 ± 3.17 | 0.018 |
AIMS65 | 0.67 ± 0.80 | 0.42 ± 0.58 | 0.008 |